Niowave, Inc.
UnclaimedPharmaceutical Preparation ManufacturingLansing, MI
Founded
2006
Primary NAICS
325412
CAGE code
4FV39
Federal awards
—
Overview
Niowave produces Actinium-225 with integrated accelerator and radiochemistry technology for reliable, scalable targeted cancer therapies.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Precision Turned Product ManufacturingAll Other Miscellaneous Electrical Equipment and Component ManufacturingResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)All Other Professional, Scientific, and Technical Services
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2024 | Department of Energy | $0 | 1 |